EXAM QUESTIONS AND CORRECT ANSWERS
WITH RATIONALES NEW 2026-2027 UPDATE
148 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Analyze molecular and cellular mechanisms underlying disease across organ systems
2 Differentiate primary versus compensatory pathophysiologic responses in complex multisystem disorders
3 Apply pathophysiologic reasoning to interpret laboratory, genetic, and hemodynamic data
4 Evaluate the impact of genetic, epigenetic, and environmental factors on disease expression
5 Synthesize mechanisms of inflammation, immunity, and coagulation to predict clinical outcomes
6 NURS 6107 Advanced Pathophysiology Exam Questions and Correct Answers with Rationales New 2026
7 2027 Update
8 Foundations of Advanced Pathophysiology
9 Applied Advanced Pathophysiology
10 Advanced Advanced Pathophysiology
11 Advanced Pathophysiology Review
ABSTRACT
This study document brings together 148 carefully worded exam questions drawn from NURS
6107 Advanced Pathophysiology Exam Questions and Correct Answers with Rationales New
2026-2027 Update, with the strongest emphasis placed on Analyze molecular and cellular
mechanisms underlying disease across organ systems, Differentiate primary versus compensatory
pathophysiologic responses in complex multisystem disorders, Apply pathophysiologic reasoning
to interpret laboratory, genetic and and hemodynamic data. Every item follows the wording style
and level of reasoning you meet in the real paper, and each one is paired with a clear rationale so
the correct choice is never a guess. Work through the set at your own pace, mark the questions
that slow you down, then come back to them until the reasoning feels automatic. Learners who
revise this way walk into the exam room recognising the pattern behind the questions instead of
meeting them for the first time. Keep going - steady, honest practice is what turns a difficult paper
into a comfortable pass.
Page 1
,Q1 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
In a cell undergoing apoptosis via the intrinsic pathway, which molecular event
directly triggers the mitochondrial outer membrane permeabilization (MOMP) that
commits the cell to death?
A. Fas ligand binding to Fas receptor
B. Bax/Bak oligomerization and pore formation CORRECT
C. Caspase-8 activation within the DISC
D. NF-B nuclear translocation
RATIONALE: The intrinsic pathway is initiated by intracellular stress, leading to Bax/Bak
activation and MOMP, which releases cytochrome c. Fas/FasL and caspase-8 are extrinsic
pathway components, and NF-B is pro-survival, not a trigger of MOMP.
Q2 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
A patient with severe sepsis develops disseminated intravascular coagulation
(DIC). Which laboratory pattern best distinguishes DIC from primary fibrinolysis?
A. Elevated D-dimer with normal platelet count
B. Prolonged PT/PTT with decreased fibrinogen and thrombocytopenia CORRECT
C. Shortened bleeding time with elevated factor VIII
D. Isolated prolongation of thrombin time with normal fibrinogen
RATIONALE: DIC is characterized by widespread activation of coagulation leading to
consumption of platelets and clotting factors (especially fibrinogen), producing prolonged PT/PTT,
thrombocytopenia, and low fibrinogen. Primary fibrinolysis typically shows normal platelet count
and fibrinogen with elevated D-dimer; the other options do not reflect the consumptive
coagulopathy of DIC.
Page 2
,Q3 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
Which genetic mechanism best explains the phenotypic variability observed in
individuals with the same pathogenic variant in a monogenic disorder such as
cystic fibrosis?
A. Anticipation due to trinucleotide repeat expansion
B. Modifier genes and environmental factors influencing disease severity CORRECT
C. Genomic imprinting leading to parent-of-origin effects
D. Mitochondrial heteroplasmy
RATIONALE: Cystic fibrosis shows wide phenotypic variability largely due to modifier genes (e.g.,
TGFB1, MBL2) and environmental exposures, not anticipation or imprinting. Mitochondrial
heteroplasmy and imprinting are relevant to other disorders, but not the primary explanation for
CF variability.
Q4 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
In a patient with chronic kidney disease, which compensatory mechanism initially
maintains glomerular filtration rate but ultimately contributes to progressive
nephron loss?
A. Decreased prostaglandin synthesis
B. Hyperfiltration in remaining nephrons via angiotensin II-mediated efferent arteriolar
constriction CORRECT
C. Increased atrial natriuretic peptide (ANP) secretion
D. Reduced renal sympathetic nerve activity
RATIONALE: Angiotensin II preferentially constricts the efferent arteriole, raising intraglomerular
pressure and causing hyperfiltration in remnant nephrons, which initially preserves GFR but
leads to glomerulosclerosis. Reduced prostaglandins and ANP do not drive this maladaptive
hyperfiltration; reduced sympathetic activity would lower renin release.
Page 3
, Q5 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
Which statement best explains why a patient with a large right-sided hemispheric
stroke may exhibit ipsilateral gaze deviation and contralateral hemiparesis?
A. Damage to the right frontal eye field impairs horizontal gaze toward the left, while
corticospinal fibers decussate in the medulla. CORRECT
B. The stroke disrupts the right optic tract, causing contralateral homonymous hemianopsia.
C. The stroke affects the right cerebellum, leading to intention tremor and ataxia.
D. The stroke involves the right thalamus, causing contralateral sensory loss.
RATIONALE: The right frontal eye field normally drives gaze to the left; its destruction causes
gaze preference toward the lesion (right). Corticospinal fibers cross in the medulla, so right
hemispheric damage causes left hemiparesis. The other options describe different anatomic
lesions and clinical findings.
Q6 ANALYZE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING DISEASE ACROSS
ORGAN SYSTEMS
A patient with type 2 diabetes has a fasting glucose of 180 mg/dL and an HbA1c of
9.5%. Which pathophysiologic mechanism primarily accounts for the elevated
fasting glucose?
A. Increased hepatic gluconeogenesis due to insulin resistance and excess glucagon
CORRECT
B. Impaired incretin effect reducing postprandial insulin secretion
C. Decreased renal glucose reabsorption
D. Enhanced peripheral glucose uptake
RATIONALE: In type 2 diabetes, insulin resistance and relative glucagon excess drive increased
hepatic gluconeogenesis, a major contributor to fasting hyperglycemia. Impaired incretin effect
and decreased renal reabsorption would not elevate fasting glucose; enhanced peripheral uptake
would lower it.
Page 4